Topics
AMD
Clinical Trial Closeup
Coding & Medicare
DME
Editor's Page
Genetics
Imaging & Diagnostics
News
RVO
Stem Cells
Surgical Pearl Video
Surgical Techniques & Tools
Uveitis
Vitrectomy
Current Issue
Archive
CME
January / February 2022
Features
Pipeline Report: New entries continue to exceed exits
Exits for discontinued programs (three over two years) exceed exits for approvals (two).
Peripheral lesions take DR imaging beyond ETDRS
Ultra-widefield imaging and artificial intelligence have called into question standards based on film photography.
Why not vitrectomy for vitreous opacities?
Why pars plana vitrectomy has come of age for vitreous opacities in selected patients.
AAO Report: New insights into ILM tears, trial readouts and more
Five abstracts on gene therapy and role of central subfield thickness in diabetic macular edema, vitreous hemorrhage and retinopathy of prematurity.
Departments
Coding Commentary
Time for a financial deep dive
A review of your practice’s financial metrics can help you spot problems in your billing system.
Editor's Page
2022: Banner year for clinical trials
Imaging Forum
Vision loss tied to cancer history
How imaging helped diagnose the cause of vision problems in a woman with endometrial adenocarcinoma.
News
Retina Update: Is Vabysmo the next $1 billion anti-VEGF?
Social Media Specialist
Social media and CME
A close look at the future of lifelong learning in the Twitter era.
Surgical Pearl Video
Strategies for PVD induction
A review of surgical methods to aid in posterior vitreous detachment induction.
Uveitis Forum
Uveitis risk of ICPIs for cancer
Immune checkpoint inhibitors are becoming more widely available, but they’ve been linked to uveitis in some patients.
Current Issue
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Connect With Us
Continuing Medical Education
Breaking New Ground: Reducing Treatment Burden in nAMD
CME Monograph
View More CME
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
View More Publications
Review Of Ophthalmology
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Should You Change Your Practice Model?
Corneal Neovascularization and Lipid Keratopathy
ARVO Annual Meeting Report
×
Full Image